Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.80

€0.80

-1.310%
-0.0109
-1.310%
€2.06

€2.06

 
12.12.25 / Tradegate WKN: A1JUDY / Symbol: MVIS / Name: MicroVision / Stock / Healthcare Equipment & Supplies / Small Cap /
Latest predictions
€2.59
12.11.25
-0.35%
buy
€1.72
21.10.25
-22.58%
buy
€1.71
05.09.25
-15.17%
buy
€2.56
02.09.25
-18.94%
buy
€1.72
27.08.25
-18.22%
buy
€2.21
21.05.25
-15.16%
buy
Your prediction

MicroVision Inc Stock

A loss of -1.310% shows a downward development for MicroVision Inc.
We see a rather positive sentiment for MicroVision Inc with 12 Buy predictions and 1 Sell predictions.
With a target price of 2 € there is potential for a 148.69% increase which would mean more than doubling the current price of 0.8 € for MicroVision Inc.
So far the community has only identified positive things for MicroVision Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of MicroVision Inc in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of MicroVision Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
MicroVision Inc -1.310% 2.121% -0.777% 0.941% -47.643% -70.634% -65.396%
Fonar Corp. New 2.480% 0.000% -2.362% -15.068% -12.676% -25.301% -21.519%
Fluidigm Corp. 0.000% 3.333% 25.253% -30.726% -27.485% 0.040% -75.715%
Allscripts Healthcare -5.560% 0.000% -5.556% -63.043% -60.000% -80.117% -70.435%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-10

MicroVision, a company operating in the Healthcare Equipment & Supplies industry with the US symbol MVIS, presents an interesting financial picture. A cursory glance at the company's financial statements reveals some areas of concern, as well as certain promising aspects. The financials indicate potential challenges with liquidity, profitability, and operational efficiency. However, there are also signs of improvement in specific areas. In this detailed analysis, we will delve into the pros and cons of MicroVision's financials.

Reduced Net Loss: The year-over-year (YoY) net loss for MicroVision has been steadily decreasing. In 2020, it was -$13,634,000, improving to -$43,200,000 in 2021, and -$53,091,000 in 2022. This decrease in net losses can be considered a positive sign for the company, as it could indicate an improvement in financial performance.

Positive Cash Flow from Financing: The cash flow statements show positive cash flow from financing activities in recent years. For instance, it was $13,164,000 in the first quarter of 2023, which may suggest that the company is receiving adequate support from investors and lenders.

Comments

Prediction Buy
Perf. (%) -0.35%
Target price 2.591
Change
Ends at 12.11.26

Microvision (NASDAQ:MVIS) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $3.00 price target on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -22.58%
Target price 1.718
Change
Ends at 21.10.26

Microvision (NASDAQ:MVIS) had its "buy" rating reaffirmed by analysts at Westpark Capital. They now have a $2.00 price target on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -15.17%
Target price 1.715
Change
Ends at 05.09.26

Microvision (NASDAQ:MVIS) had its "buy" rating reaffirmed by analysts at Westpark Capital. They now have a $2.00 price target on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

News

MicroVision Announces Third Quarter 2025 Results
MicroVision Announces Third Quarter 2025 Results

REDMOND, WASHINGTON / ACCESS Newswire / November 11, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today

MicroVision Collaborates with Leading Photonics Ecosystem to Acquire FMCW Lidar Business
MicroVision Collaborates with Leading Photonics Ecosystem to Acquire FMCW Lidar Business

REDMOND, WA / ACCESS Newswire / November 10, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced

MicroVision Appoints Glen DeVos as Chief Executive Officer
MicroVision Appoints Glen DeVos as Chief Executive Officer

REDMOND, WA / ACCESS Newswire / September 4, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced